<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Effects of a new synthetic <z:chebi fb="1" ids="35620">vasodilator</z:chebi>, YC-93, a derivative of 1 </plain></SENT>
<SENT sid="1" pm="."><plain>4-<z:chebi fb="0" ids="50075">dihydropyridine</z:chebi>, on experimental <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, were studies in cats </plain></SENT>
<SENT sid="2" pm="."><plain>A topical administration of YC-93 solution was found to rapidly reverse the spasm of the basilar artery induced with a subarachnoi application of fresh blood, <z:chebi fb="19" ids="28790">serotonin</z:chebi> or porstaglandin F2 alpha </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment of the basilar artery with YC-93 prevented the development of experimental vasospasm with <z:hpo ids='HP_0000001'>all</z:hpo> these agents </plain></SENT>
</text></document>